Pharmaceutical companies are turning to drug delivery technologies as a strategy to offset patent expiries that threaten to scuttle an estimated $25-30 billion in revenue and slow these companies' 10-15% annual sales growth.

(Photo: )

Can new and improved formulations of blockbuster drugs sustain pharmaceutical company revenues? The success or failure of these products will have a strong influence on the future of both pharmaceutical companies and the drug delivery industry.

Drug Delivery: Market Drivers, Technologies, and Companies, a DR Reports publication from Decision Resources, Inc., provides comprehensive coverage:

  -- Describes drug delivery technologies and key products.   -- Profiles leading drug delivery companies.   -- Explores industry trends including alliances and acquisitions.   -- Explains the importance of life-cycle management.   -- Identifies market drivers.   -- Outlines growth strategies.   -- Points to areas of opportunity-for example, drug delivery alternatives      for biopharmaceuticals and chemotherapies.    Products to Watch 

A particular highlight in this report is our review of five "products to watch" for their potential impact on the drug delivery industry, which is now valued at more than $40 billion and promises to be the fastest-growing segment of the pharmaceutical industry.

Drug Delivery: Market Drivers, Technologies, and Companies is available for $5,250 in print and electronic format.

Decision Resources, Inc., is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. Founded as a subsidiary of Arthur D. Little, Inc., the company has provided strategic information services for 30 years, assessing international pharmaceutical and health care industry trends. Visit Decision Resources at

   In the United States, contact Tim Daley, 781.296.2636 (tel), 781.296.2550    (fax), or    In Europe, contact Francoise Bidart, +32.2.351.4082 (tel), +32.2.351.2347    (fax), or    In Japan, contact Makiko Yoshimoto, +81.3.5401.2615 (tel),    +81.3.5401.2617 (fax), or 



AP Archive:

PRN Photo Desk, 888-776-6555 or 212-782-2840

SOURCE: Decision Resources, Inc.

Contact: Tim Daley of Decision Resources, Inc., +1-781-296-2636,

Long-Acting Psychostimulant Formulations and Novel Antidepressants Will Boost the Drug-Treated Population for Attention-Deficit/Hyperactivity Disorder, According to a Decision Resources Study

View Now